Richter Group
VC Fund
Budapest, Hungary
Richter Group is a VC fund in Budapest focused on Biotechnology and Medical. Gedeon Richter is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, central nervous system, and cardiovascular areas. Having the largest R&D unit in Central Eastern Europe,Richter's original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Richter Group invests in
Stages Richter Group invests in
Countries Richter Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Erik Bogsch
|
|||
Gabor Gulacsi
|
|||
Gedeon Richter
|
|||
Vera Tóth
|
|||
1 more contact available
Investment Focus
Industry
- Biotechnology 3 (100%)
- Medical 1 (33%)
- Robotics 1 (33%)
- Biopharma 1 (33%)
- Health Care 1 (33%)
Stage
- Seed 1 (33%)
- Corporate Round 1 (33%)
- Post-IPO Equity 1 (33%)
Country
- Israel 1 (33%)
- Germany 1 (33%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Erik Bogsch
CEO
|
CEO | Total investments: 0 | Find email | |
|
Gabor Gulacsi
Deputy Managing Director
|
Deputy Managing Director | Total investments: 0 | Find email | |
|
Gedeon Richter
Founder
|
Founder | Total investments: 2 | Find email | |
|
Vera Tóth
Medical Expert
|
Medical Expert | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Granata Bio
|
Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | Corporate Round / May 13, 2025 | |
Formycon
|
Formycon GmbH is more than a regular CRO that provides formulation and analytical services to the biopharmaceutical industry. The complete analytical development chain – starting from protein characterization and comparability studies up to GMP Quality Control and stability testing of clinical study and market medication. The Formulation one-stopshop – Formycon covers pre-formulation, development of systemic and local, liquid, freeze-dried and sustained release drug product formulations, supply of pre-clinical studies and development of the manufacturing process. | $89.8M / Post-IPO Equity / Jan 29, 2024 | |
Quris
|
Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel. | $9M / Seed / Dec 20, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Richter Group invest in?
Richter Group invests primarily in Biotechnology, Medical and Robotics startups, most often at Seed and Corporate Round stage. Most of the 3 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Richter Group?
Public channels for Richter Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Richter Group?
The team at Richter Group includes Erik Bogsch (CEO), Gabor Gulacsi (Deputy Managing Director) and Gedeon Richter (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
